GRADE - Die (Post-)Graduiertenakademie der Goethe-Universität

March 13, 2024 | 16:30 | online

Dr. Theresa Gimbel studied Biomolecular Engineering (B.Sc. & M.Sc.) at TU Darmstadt specializing in RNA biochemistry, genetics and molecular biology.

She continued her academic career with a PhD at the Institute of Cardiovascular Regeneration in the group of Prof. Dr. Reinier Boon (Goethe University Frankfurt) with the focus on the role of non-coding RNAs in age-related processes in the vasculature.
After finishing her PhD in 2022, Theresa switched to the pharmaceutical industry and joined the team of quality assurance manager in the insulin production at Sanofi.

Theresa will share the experiences she made throughout her transition to industry and talk about her daily tasks in quality management.

Click here for registration

10. January 2024 | 16:30 | online

After studying life sciences and finishing a PhD most of us face the reality of “What the heck do I do now?”. Career fairs and PhD programs provide more and more ideas what to do next but often it is not clear what industry jobs really are about.

Medical Affairs is rather young function in pharmaceutical companies and is still developing and shaping. In short Medical Affairs provides the non-sales connection to Health Care Professionals (HCPs), Patient Organizations and the connection to Clinical Research, but also provides medical expertise inside the company to other functions. In this career talk I would like to give you an idea what Medical Affairs jobs there are in the pharmaceutical industry, how a normal week is looking like for office based and field based roles, how I came to Medical Affairs and what skills are helpful to get you there.

Since Medical Affairs is an integrative function in most pharma companies, I can also provide you some side views on what my colleagues in e.g. Marketing & Sales, Compliance, Market Access and Regulatory Affairs are doing if you are interested in these functions.

Dr. Claus Schuh studied Biology at the Technical University of Kaiserslautern in Germany before doing his PhD on “Prostanoids in central and peripheral pain processing” at Gerd Geisslinger‘s Institute of Clinical Pharmacology of the University Hospital Frankfurt in the group of Klaus Scholich. Afterwards, he worked six years as a Postdoc at the Institute of Anatomy of the University of Zurich (UZH) establishing and developing in vivo renal Multiphoton Imaging in the mouse. After a short project as coordinator for clinical studies at the University Hospital Zurich he joined Sandoz/Novartis Switzerland as Medical Scientific Liaison/ Medical Advisor in July 2020. In 2023 he joined GSK in Switzerland as field based MSL.